1. 1Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, UNC-CH, Chapel Hill, North Carolina.
2. 2Lineberger Comprehensive Cancer Center (LCCC), UNC-CH, Chapel Hill, North Carolina.
3. 3Duke Cancer Institute (DCI), Chapel Hill, North Carolina.
4. 4Department of Epidemiology, Gillings School of Global Public Health, UNC-CH, Chapel Hill, North Carolina.
5. 5Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill (UNC-CH), Chapel Hill, North Carolina.